1-3 of 3
Nagavarakishore Pillarsetty
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Radioimmunotherapy Targeting Delta-like Ligand 3 in Small Cell Lung Cancer Exhibits Antitumor Efficacy with Low Toxicity

Kathryn M. Tully, Salomon Tendler, Lukas M. Carter, Sai Kiran Sharma, Zachary V. Samuels, Komal Mandleywala, Joshua A. Korsen, Avelyn Mae Delos Reyes, Alessandra Piersigilli, William D. Travis, Triparna Sen, Nagavarakishore Pillarsetty, John T. Poirier, Charles M. Rudin, Jason S. Lewis
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (7): 1391–1401.
https://doi.org/10.1158/1078-0432.CCR-21-1533
Published: 01 April 2022
View article titled, Radioimmunotherapy Targeting Delta-like Ligand 3 in Small Cell Lung Cancer Exhibits Antitumor Efficacy with Low Toxicity
Open the PDF for Radioimmunotherapy Targeting Delta-like Ligand 3 in Small Cell Lung Cancer Exhibits Antitumor Efficacy with Low Toxicity in another window
Includes: Supplementary data
Journal Articles

First-in-Human Trial of Epichaperome-Targeted PET in Patients with Cancer

Mark P.S. Dunphy, Christina Pressl, Nagavarakishore Pillarsetty, Milan Grkovski, Shanu Modi, Komal Jhaveri, Larry Norton, Bradley J. Beattie, Pat B. Zanzonico, Danuta Zatorska, Tony Taldone, Stefan O. Ochiana, Mohammad M. Uddin, Eva M. Burnazi, Serge K. Lyashchenko, Clifford A. Hudis, Jacqueline Bromberg, Heiko M. Schöder, Josef J. Fox, Hanwen Zhang, Gabriela Chiosis, Jason S. Lewis, Steven M. Larson
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (19): 5178–5187.
https://doi.org/10.1158/1078-0432.CCR-19-3704
Published: 01 October 2020
View article titled, First-in-Human Trial of Epichaperome-Targeted PET in Patients with Cancer
Open the PDF for First-in-Human Trial of Epichaperome-Targeted PET in Patients with Cancer in another window
Includes: Supplementary data
Journal Articles

Increased KIT Inhibition Enhances Therapeutic Efficacy in Gastrointestinal Stromal Tumor

Teresa S. Kim, Michael J. Cavnar, Noah A. Cohen, Eric C. Sorenson, Jonathan B. Greer, Adrian M. Seifert, Megan H. Crawley, Benjamin L. Green, Rachel Popow, Nagavarakishore Pillarsetty, Darren R. Veach, Anson T. Ku, Ferdinand Rossi, Peter Besmer, Cristina R. Antonescu, Shan Zeng, Ronald P. DeMatteo
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2014) 20 (9): 2350–2362.
https://doi.org/10.1158/1078-0432.CCR-13-3033
Published: 30 April 2014
View article titled, Increased KIT Inhibition Enhances Therapeutic Efficacy in Gastrointestinal Stromal Tumor
Open the PDF for Increased KIT Inhibition Enhances Therapeutic Efficacy in Gastrointestinal Stromal Tumor in another window
Includes: Supplementary data